Moderna Shares Fall on Report HHS Is Reviewing Bird Flu Vaccine Contract
Shares of vaccine maker Moderna dropped more than 5% late Wednesday after reports that the Health and Human Services ...
manilatimes38m
AIM Vaccine's mRNA RSV Vaccine Approved for U.S. Clinical Trials
As global capital flows positively into the pharmaceutical sector, PRC vaccine leader AIM Vaccine (06660.HK) announced on February 26 that its self-developed mRNA RSV (Respiratory Syncytial Virus) ...